Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis
- 1 January 2006
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 231 (1), 20-27
- https://doi.org/10.1177/153537020623100103
Abstract
Matrix metalloproteinase (MMP)-7, also known as matrilysin, is a “minimal domain MMP” that exhibits proteolytic activity against components of the extracellular matrix (ECM). Matrilysin is frequently overexpressed in human cancer tissues and is associated with cancer progression. Tumorigenesis is a multi-step process involving cell growth, invasion, metastasis, and angiogenesis. Matrilysin has been shown to play important roles not only in degradation of ECM proteins, but also in the regulation of several biochemical processes such as activation, degradation, and shedding of non-ECM proteins. This minireview provides a summary of the current literature on the roles of matrilysin in tumorigenesis with a focus on the roles of modifications of non-ECM proteins by matrilysin and other related MMPs in tumorigenesis. Proteolysis of insulin-like growth factor binding protein by matrilysin results in increased bioavailability of insulin-like growth factors and enhanced cellular proliferation. Matrilysin has also been implicated in the ectodomain shedding of several cell surface molecules. Heparin-binding epidermal growth factor precursor (proHB-EGF) is cleaved by matrilysin into mature HB-EGF, which promotes cellular proliferation. Membrane-bound Fas ligand (FasL) is cleaved into soluble FasL, which increases apoptosis of cells adjacent to tumor cells. E-cadherin is converted to soluble E-cadherin to promote invasion. Tumor necrosis factor (TNF)-alpha precursor is cleaved to release soluble TNF-alpha to increase apoptosis. We propose that these matrilysin-mediated pathways provide the necessary and logical mechanisms to promote cancer progression.Keywords
This publication has 53 references indexed in Scilit:
- Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailabilityBiochemical and Biophysical Research Communications, 2005
- Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteasesExperimental Cell Research, 2005
- Functional characterization of neostatins, the MMP‐derived, enzymatic cleavage products of type XVIII collagenFEBS Letters, 2005
- Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cellsExperimental Cell Research, 2005
- The role of matrix metalloproteinase 7 in innate immunityImmunobiology, 2004
- ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3Biochemical and Biophysical Research Communications, 2004
- Matrix Metalloproteinase 19 Regulates Insulin-like Growth Factor-mediated Proliferation, Migration, and Adhesion in Human Keratinocytes through Proteolysis of Insulin-like Growth Factor Binding Protein-3Molecular Biology of the Cell, 2003
- Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancerThe Journal of Pathology, 2003
- Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancersInternational Journal of Cancer, 2000
- Matrilysin: An epithelial matrix metalloproteinase with potentially novel functionsThe International Journal of Biochemistry & Cell Biology, 1996